-
Longevity in the Age of Depopulation
If there’s one thing the biotech world loves, it’s a good hype cycle. We’ve seen it with CRISPR, stem cells, mRNA vaccines, and synthetic biology. But what if…
4 min read
-
Catching Big Pharma’s attention
Catching Big Pharma attention by Avi We focus on every detail so you can relax. Let us help you tell your story Calmly. Persuasively. Memorably 🎉 We take…
4 min read
-
Biotech dreams & Startup nightmares
Let me take you back to a time when Avatar was breaking box office records, everyone was pretending to love quinoa, and I was an eager Master’s student…
4 min read
-
Three Big Questions for Canada’s Innovation Ecosystem
A Reality Check on Our Productivity Crisis Canada’s innovation ecosystem feels like a group project where everyone’s working hard, but nobody’s quite sure who’s in charge. We’ve got…
4 min read
-
Promise and Challenges of Cell Therapy
Cell therapy isn’t as new as many believe. The concept of using cells as a therapeutic tool has been around for centuries. Blood transfusions, for instance, have been…
4 min read
-
Biotech’s 2024 Insane Megarounds: Rise of Giants or a Bubble in the Making?
There’s one thing biotech VC funding loves, it’s cycles—hype, bust, and everything in between. 2024, though? This year is bringing us something different, something big—Megarounds. And when I…
4 min read
Big ideas deserve bold learning. Book a meeting and let’s get started.
